NCT06938724 2025-09-15OLTFondazione IRCCS Istituto Nazionale dei Tumori, MilanoPhase 2 Recruiting152 enrolled
NCT05134922 2025-03-21Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009Celcuity IncAvailable